Longmei Tang

Dr. Longmei Tang

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
LTLongmei Tang
Longmei Tang
SWShangchun Wu
Shangchun Wu
DLDianwu Liu
Dianwu Liu
MTMarleen Temmerman
Marleen Temmerman
WZWei-Hong Zhang
Wei-Hong Zhang
Background: In China, there were about 9.76 million induced abortions in 2019, 50% of which were repeat abortions. Understanding the tendency of repeat induced abortion and identifying its related factors is needed to develop prevention strategies. Methods: Two hospital-based cross-sectional surveys were conducted from 2005–2007 and 2013–2016 in 24 and 90 hospitals, respectively. The survey included women who sought an induced abortion within 12 weeks of pregnancy. The proportion of repeat induced abortions by adjusting the covariates through propensity score matching was compared between the two surveys, and the zero-inflated negative binomial regression model was established to identify independent factors of repeat induced abortion. Results: Adjusting the age, occupation, education, marital status and number of children, the proportion of repeat induced abortions in the second survey was found to be low (60.28% vs. 11.11%), however the unadjusted proportion was high in the second survey (44.97% vs. 51.54%). The risk of repeat induced abortion was higher among married women and women with children [ORadj and 95% CI: 0.31 (0.20, 0.49) and 0.08 (0.05, 0.13)]; the risk among service industry staff was higher when compared with unemployed women [ORadj and 95% CI: 0.19 (0.07, 0.54)]; women with a lower education level were at a higher risk of a repeat induced abortion (ORadj < 1). Compared with women under the age of 20, women in other higher age groups had a higher frequency of repeat induced abortions (IRadj: 1.78, 2.55, 3.27, 4.01, and 3.93, separately); the frequency of women with lower education levels was higher than those with a university or higher education level (IRadj > 1); the repeat induced abortion frequency of married women was 0.93 (0.90, 0.98) when compared to the frequency of unmarried women, while the frequency of women with children was 1.17 (1.10, 1.25) of childless women; the induced abortion frequency of working women was about 60–95% with that of unemployed women. Conclusions: The repeat induced abortion proportion was lower than 10 years ago. Induced abortion seekers who were married, aged 20 to 30 years and with a lower education level were more likely to repeat induced abortions.

8 December 2016 in The European Journal of Contraception & Reproductive Health Care
Verified
Journal Article
Closed access
LTLongmei Tang
Longmei Tang
SWShangchun Wu
Shangchun Wu
JLJiong Li
Jiong Li
KWKun Wang
Kun Wang
JXJialin Xu
Jialin Xu
ICINPAC Consortium
INPAC Consortium
Objective: To assess the practice of post-abortion family planning (PAFP) counselling among Chinese abortion service providers, and identify the influencing factors. Methods: A cross-sectional questionnaire survey was conducted between July and September 2013 among abortion services providers in 30 provinces in China. Univariate and multivariable logistic regression analyses were used to identify the factors that influenced PAFP counselling. Results: 94% of the 579 service providers responded to the questionnaire in the survey. The median age was 39 years (range 20–72), and 95% were females. 92% providers showed a positive attitude and had promoted the PAFP counselling services; however, only 57% spent more than 10 min for it. The overall knowledge on PAFP was limited to the participants. After adjusting for potential confounding factors: providers from the middle region (compared with ‘east region’, ORadj = 3.33, 95% CI: 2.12–5.21) conducted more PAFP counseling; providers with more knowledge (ORadj = 2.08, 95% CI: 1.38–3.15) provided more counseling; and compared with ‘middle school and below’, providers with higher education gave more counseling [ORadj(95% CI)] for ‘college’, ‘university’ and ‘master/doctor’ [1.99 (1.01,3.92), 2.32 (1.22,4.40) and 2.34 (1.06,5.17), respectively]. Conclusions: The majority of providers could provide PAFP counselling to women undergone an abortion, but some of them had insufficient time to make it available. Education, knowledge about fertility and reproductive health and residence region were the main factors influencing the practice. Training of health providers and integrating family planning as a part of abortion services are essential to provide adequate PAFP to abortion seekers, thereby reducing the risk of unintended pregnancy.

7 May 2026 in Journal of Medical Internet Research
Verified
Journal Article
Open access
JTJin Tian
Jin Tian
ZZZengren Zhao
Zengren Zhao
LTLongmei Tang
Longmei Tang
YSYongzhao Song
Yongzhao Song
YLYuchang Li
Yuchang Li
NJNan Jiang
Nan Jiang
Clinical artificial intelligence (AI) applications frequently fail to transition from short-term pilot projects into sustained components of routine clinical care, a phenomenon referred to in this viewpoint as the pilot trap. This persistent gap reflects not only technical or regulatory limitations but also insufficient governance capacity within health care organizations. We argue that such capacity is not fully established before deployment; rather, it develops through implementation as real-world operational tensions clarify organizational ownership, accountability boundaries, and coordination mechanisms. Drawing on an 18-month implementation of a provincial clinical AI platform in China, we develop a 6-module governance framework encompassing institutional carrier formation, infrastructure governance, regulatory and ethical governance, interdisciplinary coordination, translational scaling, and lifecycle evaluation and oversight. These modules represent functional governance conditions observed during implementation rather than a prescriptive institutional architecture to be installed prior to deployment. We further introduce the concept of functional transferability and position the framework as an upstream complement to existing international governance standards, which typically specify what governance should achieve, but often assume that the organizational capacity to implement it already exists. Advancing clinical AI beyond demonstration, therefore, depends less on model performance alone than on the ability of health systems to develop and sustain the institutional capacity required for routine clinical use.

1 June 2026 in Risk Management and Healthcare Policy
Verified
Journal Article
Open access
PDF file
JTJin Tian
Jin Tian
YSYongzhao Song
Yongzhao Song
LTLongmei Tang
Longmei Tang
LALejiao An
Lejiao An
JZJin Zhou
Jin Zhou
Background: Clinical artificial intelligence (AI) technologies are increasingly being introduced into hospital practice, yet evidence describing their operational integration and performance after deployment in routine clinical settings remains limited. This study examined the real-world implementation and operational integration of clinical AI within a provincial tertiary health system in China over an 18-month observation period. Methods: This retrospective longitudinal observational study used aggregated institutional data generated during routine platform deployment, including electronic medical record–linked system logs, deployment records, quality-monitoring summaries, and operational reports. The analysis focused on implementation patterns, workflow integration, selected operational indicators, and user acceptance during routine clinical use. The study evaluated implementation and operational integration rather than algorithmic accuracy, diagnostic performance, or patient-level clinical effectiveness. Results: Three AI-supported clinical pathways were included: an intelligent pre-consultation system, a multidisciplinary tumor decision-support system, and a duloxetine therapeutic drug-monitoring pathway. During the observation period, 127 clinicians across 53 specialties participated in AI-assisted clinical activities involving more than 27,000 patient encounters, 850 multidisciplinary tumor decision-support cases, and 320 therapeutic drug-monitoring episodes. Patient waiting time decreased from 18 to 13 minutes, patient satisfaction increased from 95.40% to 98.92%, consultation efficiency improved by approximately 40%, and documentation completion efficiency improved by approximately 80%. Implementation patterns differed substantially across pathways, reflecting differences in workflow position and clinical accountability rather than deployment effort alone. Conclusion: In this provincial tertiary health system, clinical AI implementation was associated with sustained operational use, cross-specialty workflow integration, and measurable changes in selected workflow indicators. These findings suggest that technical functionality alone is insufficient for sustained clinical AI use and that workflow compatibility and organizational readiness are central to routine implementation. Because this was a single-site observational study using aggregated operational data, the findings should be interpreted as implementation evidence rather than proof of clinical effectiveness. Plain Language Summary: Many hospital AI systems are tested in pilot settings but are not subsequently integrated into routine clinical operations. This study examined how a clinical AI platform was deployed in routine care at a large teaching hospital in Hebei Province, China, over an 18-month period. The study used routine hospital data, including electronic medical record–linked system logs, deployment records, quality-monitoring summaries, operational reports, and patient satisfaction information. No identifiable patient information was accessed. The analysis examined how widely the AI tools were used, which clinical services adopted them, and whether selected workflow indicators changed following routine deployment. Three AI-supported tools were included: an intelligent pre-consultation system, a multidisciplinary tumor decision-support system, and a duloxetine therapeutic drug-monitoring system. In total, 127 clinicians across 53 specialties used the platform, involving more than 27,000 patient encounters, 850 tumor decision-support cases, and 320 drug-monitoring episodes. Patient waiting time decreased from 18 to 13 minutes, patient satisfaction increased from 95.40% to 98.92%, consultation efficiency improved by approximately 40%, and documentation efficiency improved by approximately 80%. The findings suggest that clinical AI can move from pilot use into routine hospital workflows when deployment is grounded in existing clinical workflows and backed by sustained organizational support. Because this was an observational study from a single hospital, the findings should be interpreted cautiously and confirmed in other settings.

22 July 2026 in Blood Pressure
Verified
Journal Article
Closed access
JLJie Liu
Jie Liu
FWFei Wang
Fei Wang
YLYatian Liu
Yatian Liu
XLXinrui Li
Xinrui Li
DLDan Li
Dan Li
LTLongmei Tang
Longmei Tang
Environmental pollution and progressive climate change represent major contributors to the global health burden, causing over 9 million premature deaths annually. Among environmental exposures, the...

6 April 2026 in Nature Health
Verified
Journal Article
Closed access
PDF file
JLJing Liu
Jing Liu
MWMeng Wu
Meng Wu
SHSijie He
Sijie He
LYLinfeng Yang
Linfeng Yang
JZJianhong Zhao
Jianhong Zhao
JZJun Zhu
Jun Zhu